Filing Details
- Accession Number:
- 0001179110-10-003363
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-22 12:00:00
- Reporting Period:
- 2010-02-19
- Filing Date:
- 2010-02-22
- Accepted Time:
- 2010-02-22 18:22:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1314870 | Kristen Metza | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Svp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-02-19 | 12,000 | $28.26 | 18,203 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-02-19 | 8,000 | $30.95 | 26,203 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-02-19 | 17,500 | $32.79 | 43,703 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-02-19 | 37,500 | $49.01 | 6,203 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-02-19 | 12,000 | $0.00 | 12,000 | $28.26 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-02-19 | 8,000 | $0.00 | 8,000 | $30.95 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-02-19 | 17,500 | $0.00 | 17,500 | $32.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2016-05-09 | No | 4 | M | Direct | |
| 12,000 | 2016-07-26 | No | 4 | M | Direct | |
| 19,500 | 2017-01-22 | No | 4 | M | Direct |
Footnotes
- The options have a five year vesting schedule. 20% of the options vested on May 9, 2007, the first anniversary date of the grant. The balance will vest 5% every three months thereafter until fully vested on May 9, 2011.
- The options have a five year vesting schedule. 20% of the options vested on July 26, 2007, the first anniversary date of the grant. The balance will vest 5% every three months thereafter until fully vested on July 26, 2011.
- The options have a five year vesting schedule. 20% of the options vested on January 22, 2008, the first anniversary date of the grant. The balance will vest 5% every three months thereafter until fully vested on January 22, 2012.
- Sale prices reported for the transactions reported here range from $48.9901 to $49.15. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.
Billionaire Hedge Funds
